Eloise Mclennan

Big promises, hard work: What 2026 will demand from pharma It would be an understatement to describe the past year as tumultuous for the life sciences industry. Between shifting political winds, accelerating technological change, and markets that have fel... See more

FH25: Jessica DaMassa on hosting, hype, and health innovation As one of Frontiers Health’s most recognisable faces (and voices), Jessica DaMassa, founder of WTF Health and long-time emcee of the conference, has had a front-row seat to the events evolution... See more

From pilots to patients: Why the UK must rethink NHS innovation adoption How can the UK accelerate medical innovation at a time when health systems are under strain and investment is slipping away? That question dominated conversations at the recent Pharm... See more

FH25: The art of connection at Frontiers Health with Aline Noizet Frontiers Healthlimited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks with Aline Noizet, founder of Digital Health Connector – a phrase that she says encapsula... See more

FH25: Exploring the intersection of patients, HCPs, and technology with Denise Silber Frontiers Healthlimited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks with Denise Silber, founder of Basil Strategies and Doctors 2.0.